Anna Cervi
Research Subjects
Anna Cervi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Fenn
Ridgeway Research Limited, Park Farm Buildings, Park Lane, St Briavels, Gloucestershire, GL15 6QX, England, UK
2 shared publications - Charlotte Wild
Ridgeway Research Limited, Park Farm Buildings, Park Lane, St. Briavels, Gloucestershire GL15 6QX, UK
2 shared publications - Colin Capner
Ridgeway Research Limited, Park Farm Buildings, Park Lane, St. Briavels, Gloucestershire GL15 6QX, UK
2 shared publications - Deiniol R. Pritchard
Naturiol Bangor Ltd., MSParc, Gaerwen, Anglesey LL60 6AG, UK
2 shared publications - Gilda Padalino
The Department of Life Sciences (DLS), Aberystwyth University, Aberystwyth SY23 3DA, UK
2 shared publications - Joseph Payne
Ridgeway Research Limited, Park Farm Buildings, Park Lane, St. Briavels, Gloucestershire GL15 6QX, UK
2 shared publications
Latest Publications
- Open Access
- 3 July 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1869
Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica
Infection with Fasciola hepatica (liver fluke) causes fasciolosis (or fascioliasis) and poses a considerable economic as well as welfare burden to both the agricultural and animal health sectors. Here, we explore the ex vivo anthelmintic potential of synthetic derivatives of hederagenin, isolated in bulk from Hedera helix. Thirty-six compounds were initially screened against F. hepatica newly excysted juveniles (NEJs) of the Italian strain. Eleven of these compounds were active against NEJs and were selected for further study, using adult F. hepatica derived from a local abattoir (provenance unknown). From these eleven compounds, six demonstrated activity and were further assessed against immature liver flukes of the Italian strain. Subsequently, the most active compounds (n = 5) were further evaluated in ex vivo dose response experiments against adult Italian strain liver flukes. Overall, MC042 was identified as the most active molecule and the EC50 obtained from immature and adult liver fluke assays (at 24 h post co-culture) are estimated as 1.07 μM and 13.02 μM, respectively. When compared to the in vitro cytotoxicity of MDBK bovine cell line, MC042 demonstrated the highest anthelmintic selectivity (44.37 for immature and 3.64 for adult flukes). These data indicate that modified hederagenins display properties suitable for further investigations as candidate flukicides.
- 3 July 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1869
Open AccessModified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica
Infection with Fasciola hepatica (liver fluke) causes fasciolosis (or fascioliasis) and poses a considerable economic as well as welfare burden to both the agricultural and animal health sectors. Here, we explore the ex vivo anthelmintic potential of synthetic derivatives of hederagenin, isolated in bulk from Hedera helix. Thirty-six compounds were initially screened against F. hepatica newly excysted juveniles (NEJs) of the Italian strain. Eleven of these compounds were active against NEJs and were selected for further study, using adult F. hepatica derived from a local abattoir (provenance unknown). From these eleven compounds, six demonstrated activity and were further assessed against immature liver flukes of the Italian strain. Subsequently, the most active compounds (n = 5) were further evaluated in ex vivo dose response experiments against adult Italian strain liver flukes. Overall, MC042 was identified as the most active molecule and the EC50 obtained from immature and adult liver fluke assays (at 24 h post co-culture) are estimated as 1.07 μM and 13.02 μM, respectively. When compared to the in vitro cytotoxicity of MDBK bovine cell line, MC042 demonstrated the highest anthelmintic selectivity (44.37 for immature and 3.64 for adult flukes). These data indicate that modified hederagenins display properties suitable for further investigations as candidate flukicides.
- Open Access
- 19 July 2022
- Published by Elsevier in Veterinary Parasitology
- Vol. 309, 109766
Flukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.
- 19 July 2022
- Published by Elsevier in Veterinary Parasitology
- Vol. 309, 109766
Open AccessFlukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.